We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Policies

News List

Navigating the Landscape of Rare Diseases: Current Trends and Future Perspectives Neeta Ratanghayra
September 29, 2024
Rising Investment and Market Dynamics, Future Perspectives in the Orphan Drug Market and The Scenario in China.
Pharmaceutical News of the Week June 8th-12th | PharmaSources.com PharmaSources/Caicai
June 22, 2020
With the second week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 8-12.
Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars Tang
January 15, 2018
The Chinese biosimilar market can reach RMB 20-30 billion in 2020...
Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars Tang
December 27, 2017
The Chinese biosimilar market can reach RMB 20-30 billion in 2020...